Pharmacotherapeutics for Advanced Practice
Nurse Prescribers with Davis Edge
6th Edition
TEST BANK
Reference: Ch. 1, Section: Prescriptive Authority and Scope of
Practice
Question Stem: A newly credentialed APRN asks whether she
may initiate a controlled opioid for a patient with acute severe
pain. Which action should she take first?
Options:
A. Prescribe the opioid immediately using her clinic DEA
registration.
B. Consult her state’s nurse practice act and facility policy for
prescriptive authority.
C. Delegate the prescribing decision to the supervising
physician.
D. Prescribe an opioid but limit the supply to 3 days without
documentation.
Correct Answer: B
Rationales:
• Correct (B): APRNs must verify state nurse practice acts
and facility policies to confirm scope and any supervisory
, or collaborative requirements before prescribing
controlled substances; this aligns with legal/regulatory
prescribing guidance.
• (A): Incorrect — possessing a DEA number alone does not
supersede state scope limits or facility rules; legal authority
depends on state law.
• (C): Incorrect — delegation does not replace the APRN’s
duty to know her own prescriptive authority; collaborative
arrangements may exist but checking law comes first.
• (D): Incorrect — limiting supply may be prudent clinically,
but doing so without first confirming legal authority and
documenting rationale is inappropriate.
Teaching Point: Always verify state and institutional
prescriptive authority before writing controlled drug
prescriptions.
Citation: Woo, T. M., & Wright, W. L. — Ch. 1, Section:
Prescriptive Authority and Scope of Practice (6th Ed.).
2.
Reference: Ch. 1, Section: Collaborative Practice Agreements
(CPAs)
Question Stem: An APRN working under a CPA is unsure
whether a newly approved medication falls within the
agreement. Best next step?
Options:
,A. Prescribe and update the CPA later.
B. Check the CPA and obtain required physician concurrence
before prescribing.
C. Refuse to prescribe any new medications under a CPA.
D. Prescribe under the supervising physician’s name without
documentation.
Correct Answer: B
Rationales:
• Correct (B): CPAs define authorized drugs and processes
for additions; APRNs should follow CPA terms and secure
required concurrence before prescribing new agents.
• (A): Incorrect — prescribing first and modifying the CPA
later risks legal and professional violations.
• (C): Incorrect — CPAs allow practice within defined
boundaries; refusing all new meds is unnecessary if proper
procedures exist.
• (D): Incorrect — prescribing under another clinician’s name
is fraudulent and unsafe.
Teaching Point: Follow CPA procedures and obtain
concurrence before adding new medications to practice.
Citation: Woo & Wright — Ch. 1, Section: Collaborative
Practice Agreements (6th Ed.).
3.
, Reference: Ch. 1, Section: Controlled Substances & DEA
Requirements
Question Stem: An APRN plans to prescribe Schedule II opioids
for chronic pain. Which regulatory requirement must she
ensure is current?
Options:
A. Hospital privileges for pain management only.
B. State controlled substance registration and an active DEA
number (if required by state).
C. A signed patient consent that absolves the prescriber of
responsibility.
D. Manufacturer’s sampling agreement.
Correct Answer: B
Rationales:
• Correct (B): Prescribing Schedule II substances requires
compliance with state controlled substance registration
rules and, where applicable, a DEA registration; these are
mandatory regulatory steps.
• (A): Incorrect — hospital privileges are distinct from
prescriptive authority and do not replace registration
requirements.
• (C): Incorrect — informed consent is good practice but
does not meet regulatory registration requirements.
• (D): Incorrect — manufacturer sampling agreements are
unrelated to registering to prescribe controlled drugs.
Teaching Point: Maintain current state and DEA
Nurse Prescribers with Davis Edge
6th Edition
TEST BANK
Reference: Ch. 1, Section: Prescriptive Authority and Scope of
Practice
Question Stem: A newly credentialed APRN asks whether she
may initiate a controlled opioid for a patient with acute severe
pain. Which action should she take first?
Options:
A. Prescribe the opioid immediately using her clinic DEA
registration.
B. Consult her state’s nurse practice act and facility policy for
prescriptive authority.
C. Delegate the prescribing decision to the supervising
physician.
D. Prescribe an opioid but limit the supply to 3 days without
documentation.
Correct Answer: B
Rationales:
• Correct (B): APRNs must verify state nurse practice acts
and facility policies to confirm scope and any supervisory
, or collaborative requirements before prescribing
controlled substances; this aligns with legal/regulatory
prescribing guidance.
• (A): Incorrect — possessing a DEA number alone does not
supersede state scope limits or facility rules; legal authority
depends on state law.
• (C): Incorrect — delegation does not replace the APRN’s
duty to know her own prescriptive authority; collaborative
arrangements may exist but checking law comes first.
• (D): Incorrect — limiting supply may be prudent clinically,
but doing so without first confirming legal authority and
documenting rationale is inappropriate.
Teaching Point: Always verify state and institutional
prescriptive authority before writing controlled drug
prescriptions.
Citation: Woo, T. M., & Wright, W. L. — Ch. 1, Section:
Prescriptive Authority and Scope of Practice (6th Ed.).
2.
Reference: Ch. 1, Section: Collaborative Practice Agreements
(CPAs)
Question Stem: An APRN working under a CPA is unsure
whether a newly approved medication falls within the
agreement. Best next step?
Options:
,A. Prescribe and update the CPA later.
B. Check the CPA and obtain required physician concurrence
before prescribing.
C. Refuse to prescribe any new medications under a CPA.
D. Prescribe under the supervising physician’s name without
documentation.
Correct Answer: B
Rationales:
• Correct (B): CPAs define authorized drugs and processes
for additions; APRNs should follow CPA terms and secure
required concurrence before prescribing new agents.
• (A): Incorrect — prescribing first and modifying the CPA
later risks legal and professional violations.
• (C): Incorrect — CPAs allow practice within defined
boundaries; refusing all new meds is unnecessary if proper
procedures exist.
• (D): Incorrect — prescribing under another clinician’s name
is fraudulent and unsafe.
Teaching Point: Follow CPA procedures and obtain
concurrence before adding new medications to practice.
Citation: Woo & Wright — Ch. 1, Section: Collaborative
Practice Agreements (6th Ed.).
3.
, Reference: Ch. 1, Section: Controlled Substances & DEA
Requirements
Question Stem: An APRN plans to prescribe Schedule II opioids
for chronic pain. Which regulatory requirement must she
ensure is current?
Options:
A. Hospital privileges for pain management only.
B. State controlled substance registration and an active DEA
number (if required by state).
C. A signed patient consent that absolves the prescriber of
responsibility.
D. Manufacturer’s sampling agreement.
Correct Answer: B
Rationales:
• Correct (B): Prescribing Schedule II substances requires
compliance with state controlled substance registration
rules and, where applicable, a DEA registration; these are
mandatory regulatory steps.
• (A): Incorrect — hospital privileges are distinct from
prescriptive authority and do not replace registration
requirements.
• (C): Incorrect — informed consent is good practice but
does not meet regulatory registration requirements.
• (D): Incorrect — manufacturer sampling agreements are
unrelated to registering to prescribe controlled drugs.
Teaching Point: Maintain current state and DEA
